We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Intravenous methylprednisolone for multiple sclerosis in relapse.
- Authors
Barnes, M P; Bateman, D E; Cleland, P G; Dick, D J; Walls, T J; Newman, P K; Saunders, M; Tilley, P J
- Abstract
A randomised comparison is made between methylprednisolone, 1 g intravenously daily for 7 days, and a standard ACTH regime for the treatment of multiple sclerosis in acute relapse. It is found that methylprednisolone produces a more rapid clinical improvement than ACTH but confers no longer term benefit when the two treatments are compared at 3 months. It is proposed that intravenous methylprednisolone does have a role to play in the management of a patient with an acute relapse of multiple sclerosis.
- Publication
Journal of neurology, neurosurgery, and psychiatry, 1985, Vol 48, Issue 2, p157
- ISSN
0022-3050
- Publication type
Journal Article
- DOI
10.1136/jnnp.48.2.157